HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.
Yongjiang Yu
The People's Hospital of Tongliang District, China
UBE2A binding to WAC through the ATR/CHK1 axis facilitates DNA damage repair, resulting in PARP inhibitor resistance in ovarian cancer